Biology-driven stratification of advanced biliary tract cancer treated with nab-paclitaxel plus gemcitabine–cisplatin: A prospective observational cohort study
This study demonstrated the clinical activity of Gem/Cis/nab-P in advanced BTC and highlighted that biology-driven patient stratification based on genomic and transcriptomic features may provide important prognostic information.
Authors
- Min Je Sung (ORCID: https://orcid.org/0000-0001-5395-8851)
- Gwangil Kim (ORCID: https://orcid.org/0000-0002-4867-9003)
- Chansik An (ORCID: https://orcid.org/0000-0002-0484-6658)
- Sohyun Hwang (ORCID: https://orcid.org/0000-0003-2461-6806)
- Seok Jeong Yang
- Chang‐Il Kwon (ORCID: https://orcid.org/0000-0003-3621-9023)
- Sanghoon Jung (ORCID: https://orcid.org/0000-0003-2473-6453)
- Gae Hoon Jo
- Hong Jae Chon (ORCID: https://orcid.org/0000-0002-6979-5812)
- Beodeul Kang (ORCID: https://orcid.org/0000-0001-5177-8937)
- Sung Hwan Lee (ORCID: https://orcid.org/0000-0003-3365-0096)
- Suk Pyo Shin (ORCID: https://orcid.org/0000-0002-5282-9174)
- Chan Kim (ORCID: https://orcid.org/0000-0001-9780-6155)
- Jung Sun Kim (ORCID: https://orcid.org/0000-0003-1132-5217)
- Haeyoun Kang
- Seonjeong Woo
Institutions
- CHA University Bundang Medical Center (KR)
- CHA University (KR)
Publication Details
- Journal
- Hepatology
- Published
- 2025-12-19
- DOI
- https://doi.org/10.1097/hep.0000000000001650
- Citations
- 1
- Primary Topic
- Cholangiocarcinoma and Gallbladder Cancer Studies
- Type
- article
- Field-Weighted Citation Impact
- 2.01